Carlos Alban, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 17,184 shares at $54.42 ($934K) on 2010-03-01, disclosed to the SEC on 2010-03-02.
Scheduled sale ($934k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.12 | 3,920 | $212K | 22.7% |
| 2 | $54.42 | 6,564 | $357K | 38.2% |
| 3 | $54.42 | 6,700 | $365K | 39.0% |
| Total | $54.35 avg | 17,184 | $934K | 100% |
| Filing → |
| ABBV | SELL | 2018-03-02 | $19.1M | — | Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |